Company profile: Reflectance Medical
1.1 - Company Overview
Company description
- Provider of the Mobile CareGuide sensor platform for noninvasive, continuous assessment of patient metabolic status; developing new technology to improve care of critically ill patients and reduce medical costs and deaths associated with conditions resulting in poor tissue perfusion and acidosis; its noninvasive CareGuide patient monitor continuously and quantitatively displays levels.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reflectance Medical
MC3 Cardiopulmonary
HQ: United States
Website
- Description: Provider of cardiopulmonary devices, including the Nautilus Smart ECMO module for extracorporeal life support with blood oxygenation, CO2 removal, and temperature regulation via integrated sensors and touch-screen monitoring; the Crescent Jugular Dual Lumen Catheter for V-V ECMO in acute respiratory failure; and the Soft-Flow Arterial Cannula for gentle aortic perfusion, distributed globally by Medtronic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MC3 Cardiopulmonary company profile →
Spacelabs Healthcare
HQ: United States
Website
- Description: Provider of medical equipment and services to hospitals, clinics, and physician offices, offering patient monitoring and connectivity solutions, diagnostic cardiology, clinical informatics for collecting, analyzing, and visualizing clinical data, supplies and accessories, and Sentinel 11, a cardiology data management system enhancing security and accessibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spacelabs Healthcare company profile →
CeloNova BioSciences
HQ: United States
Website
- Description: Provider of interventional cardiology and endovascular products, including Polyzene-F nano-thin biomimetic coatings for implants to reduce thrombogenicity, inflammation and promote rapid healing; Xero-Gel drug-coated PTCA balloons for small vessel stenosis, restenosis and bifurcations; and COBRA PzF NanoCoated non-drug eluting coronary stents for patients with a short 1-month dual antiplatelet therapy requirement. Offers partnership and co-development opportunities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CeloNova BioSciences company profile →
Invatec
HQ: United States
Website
- Description: Provider of interventional coronary and peripheral products, focused on the development and commercialization of research-driven technologies. Headquartered in Europe, the company collaborates with physicians and centers of excellence to create products aimed at improving life expectancy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invatec company profile →
Okami Medical
HQ: United States
Website
- Description: Provider of devices for heart disease treatment, including the LOBO Vascular Occlusion System—a low-profile braided occluder enabling rapid, reliable peripheral artery vessel occlusion. Offerings include LOBO-3 (cleared for peripheral artery occlusion) and LOBO-5, LOBO-7, and LOBO-9 (FDA 510(k) cleared) for peripheral embolization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Okami Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reflectance Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reflectance Medical
2.2 - Growth funds investing in similar companies to Reflectance Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reflectance Medical
4.2 - Public trading comparable groups for Reflectance Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →